53.86MMarket Cap
LossP/E TTM
Kezar Life Sciences Inc's Company Valuation
Currency: USD Updated: 2026-05-08The current valuation score of Kezar Life Sciences Inc is 7.39, ranking 121 out of 384 in the Biotechnology & Medical Research industry. Its current P/E ratio is -0.95, which is -110.97% below the recent high of 0.10 and -7481.50% above the recent low of -72.17.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.